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G-band analysis. Partial karyotype showing the t(10;11)(q25;p15). Courtesy I Lahortiga, María J Calasanz and María D Odero. 
Department of Genetics, University of Navarra, Spain. 
 
Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia with biphenotipic 
characteristics (T/myeloid). 
Epidemiology 
Very rare, only one case described. 
Clinics 
Adenopathies, moderate splenomegaly. Two different 
morphological populations detected by flow cytometry. 
Treatment 
Hematological and cytogenetic remission after 
induction therapy (Ara-C, Idarubicin, VP-16). 
Postremission therapy (two courses of Ida-Ara-C and
mitoxantrone-Ara-C). Autologous transplantation. 
Relapse and exitus. 
Evolution 







No variants described. 
 










FISH analyses. Left BAC RPCI-11 348A20 (red, covering NUP98) shows a split compatible with the molecular breakpoint found; RPCI-11 
555F1 (green, 500 Kb telomeric to NUP98) labels normal chromosome 11 and der(10). Right BAC RPCI-11 252O7 (green, covering 
ADD3) shows a split compatible with the molecular breakpoint found; RPCI-11 348A20 shows the split in NUP98. Courtesy I Lahortiga, 
María J Calasanz and María D Odero. Department of Genetics, University of Navarra, Spain. 
 





This gene is involved only in this translocation. 
DNA/RNA 
15 exons spanning 129.52 Kb on 10q25.1-10q25.2. 
Transcription is from centromere to telomere. 2-3 
alternative transcripts. 
Protein 
Is membrane-cytoskeleton-associated protein that 
promotes the assembly of the spectrin-actin network 
and binds to calmodulin. Adducins are heteromeric 
proteins composed of different subunits referred to as 
adducin alpha, beta and gamma encoded by distinct 
genes and belong to a family of membrane skeletal 
proteins involved in the assembly of spectrin-actin 
network in erythrocytes and at sites of cell-cell contact 
in epithelial tissues. Structurally, each subunit is 
comprised of two distinct domains. The amino-terminal 
region is protease resistant and globular in shape, while 
the carboxy-terminal region is protease sensitive. The
latter contains multiple phosphorylation sites for 
protein kinase C, the binding site for calmodulin, a d is 
required for  
association with spectrin and actin. Alternatively 
spliced adducin gamma transcripts encoding different 
isoforms have been described. The functions of the 





33 exons spanning 122.54 Kb on 11p15. Transcription 
is from centromere to telomere. 3-4 alternative 
transcripts. 
Protein 
Nup98 and Nup96 play a role in the bidirectional 
transport across the nucleoporin complex (NPC). The
repeat domain in Nup98 has a direct role in the 
transport. Signal-mediated nuclear import and export 
proceed through the nuclear pore complex (NPC), 
which is comprised of approximately 50 unique 
proteins collectively known as nucleoporins. The 98 kD 
nucleoporin is generated through a biogenesis pathway 
that involves synthesis and proteolytic cleavage of a 
186 kD precursor protein. This cleavage results in the 
98 kD nucleoporin as well as a 96 kD nucleoporin, both 
of which are localized to the nucleoplasmic side of the 
NPC. The human gene has been shown to fuse to 
several genes following chromosome translocatons in 
acute myelogenous leukemia (AML) and T-cell acute  






Atlas Genet Cytogenet Oncol Haematol. 2005; 9(2)  
 
160 
lymphocytic leukemia (T-ALL). This gene is one of 
several genes located in the imprinted gene domain of 
11p15.5, an important tumor-suppressor gene region. 
Alterations in this region have been associated with the 
Beckwith-Wiedemann syndrome, Wilms tumor, 
rhabdomyosarcoma, adrenocortical carcinoma, and 
lung, ovarian, and breast cancer. Alternative splicing of 
this gene results in several transcript variants; however, 
not all variants have been fully described. 




Fusion in-frame between NUP98 exon 10 and ADD3 
exon 13 (transcript variant 1) and between NUP98 exon 
10 and ADD3 exon 14 (transcript variant 2)r. 
Transcript 




ADD3-NUP98 was also detected at a lower level. 
Fusion protein 
Description 
The fusion gene is predicted to encode a NUP98-ADD3 
protein of 566-598 aminoacids retaining the N-terminal 
FG repeat motif of NUP98 and the C-terminal 
phosphorilation sites and the calmodulin binding reion 
of ADD3. 
Oncogenesis 
In all the NUP98 fusions reported the FG-repeats are 
retained. In the NUP98 rearrangements involving the 
HOX family, the 3' region of these genes with the 
homodomain are retained so the fusion protein could 
act as an oncogenic transcription factor. In NUP98 
fusions with non-HOX genes the partners have regions 
with a significant probability of adopting a coiled-coil 
conformation. In all cases the coiled-coil domain are
retained in the chimeric protein. This domain could 
promote the oligomerization of the fusion protein 
activating its oncogenic potential. 
 
 
Schematic representation of the fusion NUP98-ADD3 consecuence of the t(10;11)(q25;p15) in a T-cell acute lymphoblastic leukemia with 
biphenotipic characteristics. From up to down: ADD3, NUP98 and the putative chimeric NUP98-ADD3 structure. FG-repeats, 
phenilalanine-glycine repeats; bipartite NLS, bipartite nuclear localization signal. Coiled coil domains on ADD3 and NUP98-ADD3 are 
indicated with asterisks. 
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